KemPharm, Inc. Reports Q3 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
KemPharm (KMPH) Misses Q3 EPS by 26c
November 12, 2015 4:45 PM ESTKemPharm (NASDAQ: KMPH) reported Q3 EPS of ($0.68), $0.26 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on KemPharm (KMPH) click here.
... More